|
summary: The authors studied the immune cells in people with MS, focusing on the role played by a cell regulatory factor, named TIM-3. They found that TIM-3 regulation is altered in people with MS, and that treatment with glatiramer and interferon-beta are partially able to restore its function.
authors: Yang L, Anderson DE, Kuchroo J, Hafler DA.
source: J Immunol. 2008 Apr 1;180(7):4409-4414
weblink: click here
category: Immunology
related research news: click here
glossary:
Cell
Glatiramer
Immunoglobulin
Immunosuppressio
Interferon
Multiple sclerosis
Sclerosis
|
